Showing results (91-100 of 540) with videos related to

Sort By:
Pageof 54
The Journal of Urology|April 1, 1992
Effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemotherapy for urogenital cancer. Urological rhG-CSF Study GroupY Aso, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 31, 2000
[New combination chemotherapy in urological cancers]K Hattori, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2000
[Assessment of quality of life as an endpoint of cancer treatment]A Hinotsu, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 30, 2001
[Verify the optimum administration of anticancer agent--cisplatin]N Miyanaga, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 30, 2001
[Prostate cancer]K Uchida, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 2, 2001
[Management of a hormone dependent cancer with endocrine therapy--prostate cancer]S Tsukamoto, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1996
[The role of etoposide therapy in urogenital cancer]K Kawai, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1996
[Salvage therapy for refractory testicular cancer]K Kawai, H Akaza
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 29, 1998
[Recent advance in luteinizing hormone-releasing hormone analogue therapy in management of prostate cancer]K Kawai, H Akaza
Cancer|April 1, 1995
Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patientsF Civantos, M A Marcial, E R Banks, et al.
Pageof 54